Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mendez MM"'
Autor:
Mendez MM, Folgado J, Tormo C, Artero A, Ascaso M, Martinez-Hervás S, Chaves FJ, Ascaso JF, Real JT
Publikováno v:
JOURNAL OF DIABETES AND ITS COMPLICATIONS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Distal symmetric peripheral polyneuropathy (DSPN) is a highly prevalent complication of diabetes. However, underlying pathophysiological mechanisms are multiple and not well understood. The aim of our study was to analyze the oxidative stress levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ab94ac835d894923674bcb1e75b5ec78
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1292
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1292
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Soto Rodriguez NA; Electrical Department, Research and Advanced Studies Center of the National Polytechnic Institute of Mexico (CINVESTAV), Mexico City, Mexico., Arroyo Kuribreña C; Departamento de Urología Hospital ángeles Puebla y Escuela de Medicina, Universidad Anáhuac Puebla, México, Puebla, Mexico., Porras Hernández JD; División de Cirugía, Hospital para El Niño Poblano, Puebla México., Gutiérrez-Gnecchi JA; Departamento de Ingeniería Electrónica, Instituto Tecnológico de Morelia, Morelia, Michoacán, México., Pérez-Escamirosa F; Instituto de Ciencias Aplicadas y Tecnología (ICAT), Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico., Rigoberto MM; Facultad de Ingeniería de La Universidad Autónoma Del Estado de México, Toluca, Mexico., Minor-Martinez A; Electrical Department, Research and Advanced Studies Center of the National Polytechnic Institute of Mexico (CINVESTAV), Mexico City, Mexico., Lorias-Espinoza D; Electrical Department, Research and Advanced Studies Center of the National Polytechnic Institute of Mexico (CINVESTAV), Mexico City, Mexico.
Publikováno v:
Surgical innovation [Surg Innov] 2023 Aug; Vol. 30 (4), pp. 493-500. Date of Electronic Publication: 2023 Apr 14.
Autor:
Zhou X; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Besse A; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen., Peter J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Steinhardt MJ; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Vogt C; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Nerreter S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Teufel E; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Stanojkovska E; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Xiao X; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Hornburger H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Haertle L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Lopez MM; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen., Munawar U; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Riedel A; Mildred Scheel Early Career Center, University of Würzburg, Würzburg., Han S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Maurits E; Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre, Leiden., Overkleeft HS; Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre, Leiden., Florea B; Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre, Leiden., Einsele H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Kortüm KM; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Driessen C; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen. christoph.driessen@kssg.ch., Besse L; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen., Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany; Mildred Scheel Early Career Center, University of Würzburg, Würzburg.
Publikováno v:
Haematologica [Haematologica] 2023 Jun 01; Vol. 108 (6), pp. 1628-1639. Date of Electronic Publication: 2023 Jun 01.
Autor:
Xiao L; Department of Organismal Biology, Uppsala University, Norbyvägen 18A, SE-752 36, Uppsala, Sweden., Johansson S; Department of Materials Science and Engineering, Science for Life Laboratory, Uppsala University, Box 35, SE-751 03, Uppsala, Sweden., Rughöft S; Department of Organismal Biology, Uppsala University, Norbyvägen 18A, SE-752 36, Uppsala, Sweden., Burki F; Department of Organismal Biology, Uppsala University, Norbyvägen 18A, SE-752 36, Uppsala, Sweden., Sandin MM; Department of Organismal Biology, Uppsala University, Norbyvägen 18A, SE-752 36, Uppsala, Sweden., Tenje M; Department of Materials Science and Engineering, Science for Life Laboratory, Uppsala University, Box 35, SE-751 03, Uppsala, Sweden., Behrendt L; Department of Organismal Biology, Uppsala University, Norbyvägen 18A, SE-752 36, Uppsala, Sweden. lars.behrendt@scilifelab.uu.se.
Publikováno v:
The ISME journal [ISME J] 2022 Aug; Vol. 16 (8), pp. 2060-2064. Date of Electronic Publication: 2022 Apr 26.
Publikováno v:
Journal of health care for the poor and underserved [J Health Care Poor Underserved] 2022; Vol. 33 (1), pp. 551-557.
Autor:
Prange L; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Pratt M; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Herman K; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Schiffmann R; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Mueller DM; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., McLean M; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Mendez MM; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Walley N; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Heinzen EL; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Goldstein D; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Shashi V; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Hunanyan A; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Pagadala V; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC., Mikati MA; Duke University (L.P., M.P., M.M.M., N.W., V.S., A.H., M.A.M.), Durham, NC; UC Davis Health (K.H.), Sacramento; Baylor Scott & White Health (R.S.), Dallas, TX; Rosalind Franklin University of Medicine and Science (D.M.M.), Chicago, IL; University of North Carolina at Chapel Hill (E.L.H.); Columbia University (D.G.), New York City, NY; and Glycan Therapeutics, LLC (V.P.), Chapel Hill, NC.
Publikováno v:
Neurology. Genetics [Neurol Genet] 2020 Aug 04; Vol. 6 (5), pp. e466. Date of Electronic Publication: 2020 Aug 04 (Print Publication: 2020).